PO₄

Phosphorus

Metabolic Panel

What is Phosphorus?

Phosphorus is the second most abundant mineral in the body after calcium, with approximately 85% stored in bones and teeth as hydroxyapatite, 14% in soft tissues, and about 1% in the extracellular fluid including blood. In the bloodstream, phosphorus exists primarily as inorganic phosphate (HPO₄²⁻ and H₂PO₄⁻), and standard lab tests measure this inorganic phosphate fraction. Phosphorus is essential for bone mineralization, energy production (as a component of ATP and creatine phosphate), cell membrane structure (phospholipids), DNA and RNA backbone, acid-base buffering, and cellular signaling.

Phosphorus homeostasis involves a complex interplay between the intestines (absorption), kidneys (excretion), bones (storage), and hormonal regulators—primarily parathyroid hormone (PTH), active vitamin D (1,25-dihydroxyvitamin D), and fibroblast growth factor 23 (FGF-23). The kidneys are the primary regulators, with approximately 80–90% of filtered phosphate being reabsorbed in the proximal tubule. Serum phosphorus levels exhibit significant diurnal variation and are affected by recent meals, making fasting samples preferred for accurate measurement.

Why It Matters

Phosphorus is critical for energy metabolism, bone health, and cellular function. High phosphorus (hyperphosphatemia) is a major complication of chronic kidney disease and is directly linked to vascular calcification, cardiovascular events, and increased mortality in CKD patients. Low phosphorus (hypophosphatemia) can cause muscle weakness, respiratory failure, hemolytic anemia, and rhabdomyolysis. Maintaining phosphorus within the normal range is especially important for patients with kidney disease, parathyroid disorders, and those receiving certain medications or nutritional support.

Normal Reference Ranges

GroupRangeUnit
Adults2.5–4.5mg/dL
Children (1–12 years)3.0–5.5mg/dL
Adolescents2.5–5.0mg/dL
Newborns4.5–9.0mg/dL

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High PO₄ Levels Mean

Common Causes

  • Chronic kidney disease (most common cause in adults)
  • Hypoparathyroidism
  • Vitamin D toxicity
  • Tumor lysis syndrome
  • Rhabdomyolysis
  • Excessive phosphate intake (supplements, laxatives, enemas)
  • Acidosis (shifts phosphate from intracellular to extracellular)

Possible Symptoms

  • Itching (pruritus)
  • Joint and bone pain
  • Muscle cramps
  • Nausea
  • Red eyes (conjunctival calcification)
  • Often asymptomatic until vascular calcification develops
  • Symptoms of associated hypocalcemia (tingling, tetany)

What to do: In CKD, managing hyperphosphatemia involves dietary phosphorus restriction (limiting processed foods, dairy, and phosphate additives), phosphate binders taken with meals (calcium-based, sevelamer, or lanthanum carbonate), and optimizing dialysis adequacy. Check PTH and vitamin D levels. In acute hyperphosphatemia (tumor lysis syndrome), aggressive IV hydration and sometimes dialysis are required. Underlying causes like vitamin D toxicity or hypoparathyroidism should be treated directly. Target phosphorus in CKD is generally <5.5 mg/dL for dialysis patients.

What Low PO₄ Levels Mean

Common Causes

  • Refeeding syndrome (most dangerous cause)
  • Hyperparathyroidism
  • Vitamin D deficiency
  • Chronic alcoholism
  • Diabetic ketoacidosis (DKA) recovery phase
  • Respiratory alkalosis (shifts phosphate intracellularly)
  • Phosphate-binding antacids (aluminum or magnesium-based)
  • Genetic disorders (X-linked hypophosphatemia)

Possible Symptoms

  • Muscle weakness and fatigue
  • Respiratory failure (diaphragm weakness)
  • Confusion and altered mental status
  • Bone pain and fractures (in chronic depletion)
  • Hemolytic anemia
  • Rhabdomyolysis
  • Cardiac dysfunction

What to do: Mild hypophosphatemia (2.0–2.5 mg/dL) can be treated with oral phosphate supplements and dietary modification (dairy products, nuts, meat, whole grains). Severe hypophosphatemia (<1.0 mg/dL) is a medical emergency requiring IV sodium or potassium phosphate with careful monitoring, as overly rapid correction can cause hypocalcemia, arrhythmias, and metastatic calcification. In refeeding syndrome, phosphorus should be repleted before advancing nutrition. Evaluate and treat underlying causes including vitamin D deficiency, hyperparathyroidism, and medication effects.

When Is PO₄ Testing Recommended?

  • When monitoring chronic kidney disease management
  • When evaluating parathyroid disorders
  • During refeeding of malnourished or starving patients
  • When investigating bone disease or unexplained fractures
  • In patients recovering from diabetic ketoacidosis
  • When taking phosphate-binding antacids long-term

Frequently Asked Questions

Refeeding syndrome is a potentially fatal condition that occurs when nutrition is reintroduced after a period of starvation or severe malnutrition. During starvation, the body depletes intracellular phosphorus stores while serum levels may remain normal. When carbohydrates are reintroduced, insulin surges drive glucose and phosphorus into cells, causing dramatic drops in serum phosphorus (sometimes to <1.0 mg/dL). This severe hypophosphatemia can cause respiratory failure, cardiac arrhythmias, seizures, rhabdomyolysis, and death. At-risk patients include those with anorexia nervosa, chronic alcoholism, prolonged fasting, and ICU patients starting enteral or parenteral nutrition. Prevention requires slow nutrition advancement with prophylactic phosphorus, potassium, magnesium, and thiamine supplementation.
Children naturally have higher phosphorus levels than adults because phosphorus is essential for bone growth and mineralization during the rapid skeletal development of childhood. Growth hormone and insulin-like growth factor 1 (IGF-1) increase renal phosphate reabsorption during growth periods, maintaining higher serum levels. As skeletal growth slows and epiphyseal plates close during adolescence, phosphorus levels gradually decline to adult ranges. This is why age-specific reference ranges are critical—a phosphorus of 5.0 mg/dL would be normal in a 6-year-old but high in an adult.
In chronic kidney disease, the kidneys progressively lose the ability to excrete phosphorus, leading to hyperphosphatemia. Elevated phosphorus stimulates PTH secretion (secondary hyperparathyroidism) and suppresses vitamin D activation, creating a cascade that causes bone disease (renal osteodystrophy). More critically, high phosphorus directly promotes calcium-phosphate crystal deposition in blood vessel walls (vascular calcification), heart valves, and soft tissues. This vascular calcification is a major driver of the dramatically increased cardiovascular mortality seen in CKD patients. Studies consistently show that elevated phosphorus is an independent predictor of death in dialysis patients, which is why phosphorus control is a central pillar of CKD management.

Related Biomarkers

CaCalcium25(OH)DVitamin DMgMagnesiumeGFREstimated Glomerular Filtration Rate

Want your PO₄ levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.